Major Adverse Cardiac Event (MACE) is used as a clinical outcome in early-stage clinical trials for liver disease interventions, indicating cardiovascular disease risk proximity.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.